Author:
Yuen Eric C.,Liu Enchi,Kinney Gene G.
Reference91 articles.
1. Albright C, Dockens R, Olson R et al (2008) BMS-708163, a potent and selective γ-secretase inhibitor, decreases CSF Aβ at safe and tolerable doses in animals and humans. Presentation at international conference on Alzheimer’s disease, Chicago
2. Alzheimer’s Association (2010) Alzheimer’s association report: Alzheimer’s disease facts and figures. Alz Dement 6:158–194
3. Arriagada PV, Growdon JH, Hedley-Whyte ET et al (1992) Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42(3 Pt 1):631–639
4. Bacskai BJ, Hickey GA, Skoch J et al (2003) Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice. Proc Natl Acad Sci U S A 100(21):12462–12467
5. Bacskai BJ, Frosch MP, Freeman SH et al (2007) Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol 64(3):431–434